Is Medplus Health Services the Best Stock in Its Sector? A Look at the Numbers
- September 16, 2026
- Posted by: Harsh Piplani
- Category: Market
Medplus Health Services CMP Rs 653 (16 Sep 2026). Market cap Rs 7,872 Cr. ROE 11.12%. P/E 37.40x versus Industry P/E 67.04x.
Quick Answer
Medplus Health Services is one of the names investors compare when screening the Healthcare sector, built on a 11.12% return on equity and a P/E of 37.40x against an Industry P/E of 67.04x. Medplus Health Services Ltd operates a large chain of retail pharmacies across South and East India, combined with a growing online pharmacy and diagnostics business. Whether Medplus Health Services is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Medplus Health Services the best stock in its sector? The stock trades on the NSE at Rs 653 as of 16 September 2026, within its 52-week range of Rs 648.00 to Rs 1,022.20. Medplus Health Services Ltd operates a large chain of retail pharmacies across South and East India, combined with a growing online pharmacy and diagnostics business.
Medplus Health Services sits in the Healthcare sector, and its 11.12% ROE and 37.40x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Medplus Health Services
Medplus Health Services Ltd operates a large chain of retail pharmacies across South and East India, combined with a growing online pharmacy and diagnostics business. At a market capitalisation of Rs 7,872 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Medplus Health Services the Best Stock in Its Sector?
Medplus Health Services makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 11.12% ROE with a 37.40x P/E against the sector’s 67.04x Industry P/E. Medplus Health Services’ 37.40x P/E is well below the 67.04x Industry P/E, though its 11.12% ROE trails the hospital operators used elsewhere in this series, reflecting the thinner margins typical of pharmacy retail versus hospital care.
| Metric | Medplus Health Services |
|---|---|
| CMP (NSE) | Rs 652.60 |
| 52-Week High / Low | Rs 1,022.20 / Rs 648.00 |
| Market Cap | Rs 7,872 Cr |
| P/E (TTM) vs Industry P/E | 37.40x vs 67.04x |
| P/B | 3.99 |
| ROE | 11.12% |
| EPS (TTM) | Rs 17.52 |
| Dividend Yield | 0.00% |
| Debt to Equity | 0.72 |
Compare Medplus Health Services Against Other Healthcare Sector Stocks
How Medplus Health Services Compares Against Its Healthcare Sector Peers
The table below sets Medplus Health Services against 3 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 3 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Medplus Health Services | 7,872 | 37.40 | 11.12% | 0.72 |
| Apollo Hospitals Enterprise | 1,25,093 | 57.59 | 20.48% | 0.90 |
| Max Healthcare Institute | 99,964 | 68.61 | 13.42% | 0.32 |
| Global Health | 38,921 | 70.47 | 14.05% | 0.30 |
| Peer average (3 companies) | – | 65.56 | 15.98% | 0.51 |
Against this peer set, Medplus Health Services’s 11.12% ROE is below the 15.98% peer average, and its P/E of 37.40x runs below the peer average of 65.56x. Medplus Health Services’ 37.40x P/E is well below the 67.04x Industry P/E, though its 11.12% ROE trails the hospital operators used elsewhere in this series, reflecting the thinner margins typical of pharmacy retail versus hospital care.
What Makes Medplus Health Services Worth Watching in Healthcare
- Well below Industry P/E: A 37.40x P/E against a 67.04x Industry P/E is a significant discount relative to the broader Healthcare sector.
- Large pharmacy retail network: A large store count across South and East India gives Medplus scale and purchasing power in organised pharmacy retail.
- Moderate leverage: A debt to equity ratio of 0.72 is manageable for a business funding store network expansion.
Medplus Health Services Valuation: Is It Justified?
Medplus Health Services’ 37.40x P/E is well below the 67.04x Industry P/E, though its 11.12% ROE trails the hospital operators used elsewhere in this series, reflecting the thinner margins typical of pharmacy retail versus hospital care. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Bata India the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Medplus Health Services and other Healthcare sector stocks.
How to Track Medplus Health Services Before You Invest
Before deciding whether Medplus Health Services deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Medplus Health Services to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Medplus Health Services earns a place in the best stock in its sector conversation on the strength of a 11.12% ROE and a P/E of 37.40x against a 67.04x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Medplus Health Services the best stock in its sector?
Ans. Medplus Health Services has a 11.12% ROE and trades at 37.40x P/E against a 67.04x Industry P/E, and compares below the peer average ROE of 15.98% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Medplus Health Services?
Ans. Medplus Health Services was trading at Rs 652.60 on the NSE as of 16 September 2026, within its 52-week range of Rs 648.00 to Rs 1,022.20.
What sector does Medplus Health Services belong to?
Ans. Medplus Health Services is classified under the Healthcare sector on Univest.
How does Medplus Health Services compare to its sector peers on P/E?
Ans. Medplus Health Services’s P/E of 37.40x is below the 65.56x average of the 3 named peers compared in this article.
What is Medplus Health Services’s return on equity?
Ans. Medplus Health Services reported a return on equity of 11.12%, which is below the 15.98% average of its named peers in this comparison.
Should I invest in Medplus Health Services based on its sector position?
Ans. Medplus Health Services’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
